{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:35:13Z","timestamp":1788910513696,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:00:00Z","timestamp":1598832000000},"content-version":"vor","delay-in-days":700,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"HHS | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R35CA197684"],"award-info":[{"award-number":["R35CA197684"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1074\/jbc.ra118.003719","type":"journal-article","created":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T22:45:12Z","timestamp":1534891512000},"page":"15977-15990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Thioridazine inhibits self-renewal in breast cancer cells via DRD2-dependent STAT3 inhibition, but induces a G1 arrest independent of DRD2"],"prefix":"10.1016","volume":"293","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1340-9254","authenticated-orcid":false,"given":"Matthew","family":"Tegowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1246-1333","authenticated-orcid":false,"given":"Albert S.","family":"Baldwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.RA118.003719_bib1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharmacol. Rev"},{"key":"10.1074\/jbc.RA118.003719_bib2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","article-title":"Dopamine receptors: From structure to function","volume":"78","author":"Missale","year":"1998","journal-title":"Physiol. Rev"},{"key":"10.1074\/jbc.RA118.003719_bib3","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.tins.2007.03.002","article-title":"Dopamine: 50 years in perspective","volume":"30","author":"Iversen","year":"2007","journal-title":"Trends Neurosci"},{"key":"10.1074\/jbc.RA118.003719_bib4","doi-asserted-by":"crossref","first-page":"e85888","DOI":"10.1172\/jci.insight.85888","article-title":"Renal rescue of dopamine D2 receptor function reverses renal injury and high blood pressure","volume":"1","author":"Konkalmatt","year":"2016","journal-title":"JCI Insight"},{"key":"10.1074\/jbc.RA118.003719_bib5","doi-asserted-by":"crossref","first-page":"e38745","DOI":"10.1371\/journal.pone.0038745","article-title":"Deficient dopamine D2 receptor function causes renal inflammation independently of high blood pressure","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"10.1074\/jbc.RA118.003719_bib6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/apha.12476","article-title":"Dopamine and T cells: Dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases","volume":"216","author":"Levite","year":"2016","journal-title":"Acta Physiol"},{"key":"10.1074\/jbc.RA118.003719_bib7","doi-asserted-by":"crossref","first-page":"e42746","DOI":"10.1371\/journal.pone.0042746","article-title":"Quetiapine, an atypical antipsychotic, is protective against autoimmune-mediated demyelination by inhibiting effector T cell proliferation","volume":"7","author":"Mei","year":"2012","journal-title":"PLoS One"},{"key":"10.1074\/jbc.RA118.003719_bib8","doi-asserted-by":"crossref","first-page":"27026","DOI":"10.1074\/jbc.M110.144022","article-title":"D1 and D2 dopamine receptor-mediated inhibition of activated normal T cell proliferation is lost in Jurkat T leukemic cells","volume":"285","author":"Basu","year":"2010","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.003719_bib9","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.cell.2012.03.049","article-title":"Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells","volume":"149","author":"Sachlos","year":"2012","journal-title":"Cell"},{"key":"10.1074\/jbc.RA118.003719_bib10","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.3892\/or.2016.5313","article-title":"Thioridazine elicits potent antitumor effects in colorectal cancer stem cells","volume":"37","author":"Zhang","year":"2017","journal-title":"Oncol. Rep"},{"key":"10.1074\/jbc.RA118.003719_bib11","doi-asserted-by":"crossref","first-page":"6709828","DOI":"10.1155\/2016\/6709828","article-title":"Targeting lung cancer stem cells with antipsychological drug thioridazine","volume":"2016","author":"Yue","year":"2016","journal-title":"Biomed. Res. Int"},{"key":"10.1074\/jbc.RA118.003719_bib12","doi-asserted-by":"crossref","first-page":"e1753","DOI":"10.1038\/cddis.2015.77","article-title":"Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data","volume":"6","author":"Cheng","year":"2015","journal-title":"Cell Death Dis"},{"key":"10.1074\/jbc.RA118.003719_bib13","doi-asserted-by":"crossref","first-page":"882","DOI":"10.18632\/oncotarget.1801","article-title":"Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastoma","volume":"5","author":"Li","year":"2014","journal-title":"Oncotarget"},{"key":"10.1074\/jbc.RA118.003719_bib14","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.3892\/mmr.2015.3967","article-title":"Dopamine receptor antagonist thioridazine inhibits tumor growth in a murine breast cancer model","volume":"12","author":"Yin","year":"2015","journal-title":"Mol. Med. Rep"},{"key":"10.1074\/jbc.RA118.003719_bib15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0022-3565(25)10322-4","article-title":"Tamoxifen-resistant human breast cancer cell growth: inhibition by thioridazine, pimozide and the calmodulin antagonist, W-13","volume":"263","author":"Strobl","year":"1992","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1074\/jbc.RA118.003719_bib16","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1053\/j.gastro.2016.08.040","article-title":"Expression of DRD2 is increased in human pancreatic ductal adenocarcinoma and inhibitors slow tumor growth in mice","volume":"151","author":"Jandaghi","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1074\/jbc.RA118.003719_bib17","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrc3818","article-title":"Revisiting STAT3 signalling in cancer: New and unexpected biological functions","volume":"14","author":"Yu","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/jbc.RA118.003719_bib18","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.immuni.2012.03.013","article-title":"The JAK-STAT pathway at twenty","volume":"36","author":"Stark","year":"2012","journal-title":"Immunity"},{"key":"10.1074\/jbc.RA118.003719_bib19","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1172\/JCI44745","article-title":"The JAK2\/STAT3 signaling pathway is required for growth of CD44+CD24\u2212 stem cell-like breast cancer cells in human tumors","volume":"121","author":"Marotta","year":"2011","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA118.003719_bib20","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1002\/stem.1752","article-title":"STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancer","volume":"32","author":"Wei","year":"2014","journal-title":"Stem Cells"},{"key":"10.1074\/jbc.RA118.003719_bib21","doi-asserted-by":"crossref","first-page":"e52608","DOI":"10.1371\/journal.pone.0052608","article-title":"Stat3 is required to maintain the full differentiation potential of mammary stem cells and the proliferative potential of mammary luminal progenitors","volume":"7","author":"Staniszewska","year":"2012","journal-title":"PLoS One"},{"key":"10.1074\/jbc.RA118.003719_bib22","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1093\/emboj\/18.15.4261","article-title":"STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells","volume":"18","author":"Matsuda","year":"1999","journal-title":"EMBO J"},{"key":"10.1074\/jbc.RA118.003719_bib23","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1002\/ijc.29923","article-title":"Constitutive activation of STAT3 in breast cancer cells: A review","volume":"138","author":"Banerjee","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1074\/jbc.RA118.003719_bib24","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ni.3153","article-title":"IL-6 as a keystone cytokine in health and disease","volume":"16","author":"Hunter","year":"2015","journal-title":"Nat. Immunol"},{"key":"10.1074\/jbc.RA118.003719_bib25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12916-015-0416-2","article-title":"Constitutive phosphorylated STAT3-associated gene signature is predictive for trastuzumab resistance in primary HER2-positive breast cancer","volume":"13","author":"Sonnenblick","year":"2015","journal-title":"BMC Med"},{"key":"10.1074\/jbc.RA118.003719_bib26","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.molcel.2012.06.014","article-title":"Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population","volume":"47","author":"Korkaya","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1074\/jbc.RA118.003719_bib27","doi-asserted-by":"crossref","first-page":"7611","DOI":"10.1038\/sj.onc.1206004","article-title":"Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells","volume":"21","author":"Real","year":"2002","journal-title":"Oncogene"},{"key":"10.1074\/jbc.RA118.003719_bib28","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/nm.2250","article-title":"STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors","volume":"16","author":"Lee","year":"2010","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.RA118.003719_bib29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0006-8993(99)02021-1","article-title":"Dopamine stimulates redox\u2013tyrosine kinase signaling and p38 MAPK in activation of astrocytic C6-D2L cells","volume":"850","author":"Luo","year":"1999","journal-title":"Brain Res"},{"key":"10.1074\/jbc.RA118.003719_bib30","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/S0022-3565(25)39451-6","article-title":"D2 dopamine receptor stimulation of mitogenesis in transfected Chinese hamster ovary cells: Relationship to dopamine stimulation of tyrosine phosphorylations","volume":"267","author":"Lajiness","year":"1993","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1074\/jbc.RA118.003719_bib31","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/onc.2013.64","article-title":"Canonical and non-canonical NF-\u03baB signaling promotes breast cancer tumor-initiating cells","volume":"33","author":"Kendellen","year":"2014","journal-title":"Oncogene"},{"key":"10.1074\/jbc.RA118.003719_bib32","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-negative breast cancer: Challenges and opportunities of a heterogeneous disease","volume":"13","author":"Bianchini","year":"2016","journal-title":"Nat. Rev. Clin. Oncol"},{"issue":"Suppl. 5","key":"10.1074\/jbc.RA118.003719_bib33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1634\/theoncologist.2010-S5-39","article-title":"Molecular stratification of triple-negative breast cancers","volume":"15","author":"Perou","year":"2010","journal-title":"Oncologist"},{"key":"10.1074\/jbc.RA118.003719_bib34","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s00726-017-2408-3","article-title":"Validation of dopamine receptor DRD1 and DRD2 antibodies using receptor deficient mice","volume":"49","author":"Stojanovic","year":"2017","journal-title":"Amino Acids"},{"key":"10.1074\/jbc.RA118.003719_bib35","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00210-008-0384-6","article-title":"Should we be cautious on the use of commercially available antibodies to dopamine receptors?","volume":"379","author":"Bodei","year":"2009","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol"},{"key":"10.1074\/jbc.RA118.003719_bib36","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1158\/0008-5472.CAN-13-3451","article-title":"Small-molecule ONC201\/TIC10 targets chemotherapy-resistant colorectal cancer stem-like cells in an Akt\/Foxo3a\/TRAIL-dependent manner","volume":"75","author":"Prabhu","year":"2015","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.RA118.003719_bib37","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/15384101.2017.1421035","article-title":"ONC201 shows promise in AML treatment","volume":"17","author":"Edwards","year":"2018","journal-title":"Cell Cycle"},{"key":"10.1074\/jbc.RA118.003719_bib38","doi-asserted-by":"crossref","first-page":"18454","DOI":"10.18632\/oncotarget.24862","article-title":"ONC201 kills breast cancer cells in vitro by targeting mitochondria","volume":"9","author":"Greer","year":"2018","journal-title":"Oncotarget"},{"key":"10.1074\/jbc.RA118.003719_bib39","doi-asserted-by":"crossref","unstructured":"Madhukar, N. S., Khade, P., Huang, L., Gayvert, K., Galletti, G., Stogniew, M., Allen, J. E., Giannakakou, P., and Elemento, O. (2017) A new big-data paradigm for target identification and drug discovery bioRxiv 10.1101\/134973 10.1101\/134973","DOI":"10.1101\/134973"},{"key":"10.1074\/jbc.RA118.003719_bib40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ccr.2009.01.001","article-title":"IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer","volume":"15","author":"Grivennikov","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1074\/jbc.RA118.003719_bib41","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/bcr3473","article-title":"A mutual activation loop between breast cancer cells and myeloid-derived suppressor cells facilitates spontaneous metastasis through IL-6 trans-signaling in a murine model","volume":"15","author":"Oh","year":"2013","journal-title":"Breast Cancer Res"},{"key":"10.1074\/jbc.RA118.003719_bib42","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10549-013-2488-z","article-title":"The role of intratumoral and systemic IL-6 in breast cancer","volume":"138","author":"Dethlefsen","year":"2013","journal-title":"Breast Cancer Res. Treat"},{"key":"10.1074\/jbc.RA118.003719_bib43","doi-asserted-by":"crossref","first-page":"11553","DOI":"10.1007\/s13277-016-5098-7","article-title":"Role of interleukin-6 in cancer progression and therapeutic resistance","volume":"37","author":"Kumari","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1074\/jbc.RA118.003719_bib44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nature11691","article-title":"Automated design of ligands to polypharmacological profiles","volume":"492","author":"Besnard","year":"2012","journal-title":"Nature"},{"key":"10.1074\/jbc.RA118.003719_bib45","doi-asserted-by":"crossref","first-page":"15460","DOI":"10.18632\/oncotarget.7102","article-title":"Potential therapeutic implications of IL-6\/IL-6R\/gp130-targeting agents in breast cancer","volume":"7","author":"Heo","year":"2016","journal-title":"Oncotarget"},{"key":"10.1074\/jbc.RA118.003719_bib46","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.neo.2017.10.002","article-title":"Role of dopamine receptors in the anticancer activity of ONC201","volume":"20","author":"Kline","year":"2018","journal-title":"Neoplasia"},{"key":"10.1074\/jbc.RA118.003719_bib47","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0165-5728(02)00280-1","article-title":"Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study","volume":"132","author":"McKenna","year":"2002","journal-title":"J. Neuroimmunol"},{"key":"10.1074\/jbc.RA118.003719_bib48","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jneuroim.2009.09.001","article-title":"The U937 macrophage cell line expresses enzymatically active l-Dopa decarboxylase","volume":"216","author":"Kokkinou","year":"2009","journal-title":"J. Neuroimmunol"},{"key":"10.1074\/jbc.RA118.003719_bib49","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/intimm\/dxp033","article-title":"Dopamine released by dendritic cells polarizes Th2 differentiation","volume":"21","author":"Nakano","year":"2009","journal-title":"Int. Immunol"},{"key":"10.1074\/jbc.RA118.003719_bib50","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1046\/j.1365-2567.1996.d01-653.x","article-title":"Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis","volume":"88","author":"Josefsson","year":"1996","journal-title":"Immunology"},{"key":"10.1074\/jbc.RA118.003719_bib51","doi-asserted-by":"crossref","first-page":"12912","DOI":"10.1073\/pnas.91.26.12912","article-title":"Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop","volume":"91","author":"Bergquist","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA118.003719_bib52","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1182\/blood-2006-01-028423","article-title":"Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine\/paracrine inhibitory functional loop","volume":"109","author":"Cosentino","year":"2007","journal-title":"Blood"},{"key":"10.1074\/jbc.RA118.003719_bib53","doi-asserted-by":"crossref","first-page":"15641","DOI":"10.1074\/jbc.M110.188078","article-title":"Wnt5a-dopamine D2 receptor interactions regulate dopamine neuron development via extracellular signal-regulated kinase (ERK) activation","volume":"286","author":"Yoon","year":"2011","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.003719_bib54","doi-asserted-by":"crossref","first-page":"32101","DOI":"10.18632\/oncotarget.16646","article-title":"Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenografts","volume":"8","author":"Gwynne","year":"2017","journal-title":"Oncotarget"},{"key":"10.1074\/jbc.RA118.003719_bib55","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1126\/science.aah5072","article-title":"Adrenergic nerves activate an angio-metabolic switch in prostate cancer","volume":"358","author":"Zahalka","year":"2017","journal-title":"Science"},{"key":"10.1074\/jbc.RA118.003719_bib56","doi-asserted-by":"crossref","first-page":"1236361","DOI":"10.1126\/science.1236361","article-title":"Autonomic nerve development contributes to prostate cancer progression","volume":"341","author":"Magnon","year":"2013","journal-title":"Science"},{"key":"10.1074\/jbc.RA118.003719_bib57","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.ccell.2016.05.002","article-title":"Inhibition of dopamine receptor D4 impedes autophagic flux, proliferation, and survival of glioblastoma stem cells","volume":"29","author":"Dolma","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1074\/jbc.RA118.003719_bib58","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nmeth.1638","article-title":"A public genome-scale lentiviral expression library of human ORFs","volume":"8","author":"Yang","year":"2011","journal-title":"Nat. Meth"},{"key":"10.1074\/jbc.RA118.003719_bib59","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.1074\/jbc.M116.771964","article-title":"Cytosolic DNA promotes signal transducer and activator of transcription 3 (STAT3) phosphorylation by TANK-binding kinase 1 (TBK1) to restrain STAT3 activity","volume":"292","author":"Hsia","year":"2017","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.003719_bib60","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.cell.2015.09.033","article-title":"Comprehensive molecular portraits of invasive lobular breast cancer","volume":"163","author":"Ciriello","year":"2015","journal-title":"Cell"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820351371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820351371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.RA118.003719","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T13:05:16Z","timestamp":1751807116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820351371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":60,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0021925820351371"],"URL":"https:\/\/doi.org\/10.1074\/jbc.ra118.003719","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thioridazine inhibits self-renewal in breast cancer cells via DRD2-dependent STAT3 inhibition, but induces a G1 arrest independent of DRD2","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.RA118.003719","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Tegowski et al.","name":"copyright","label":"Copyright"}]}}